Royalty Pharma Net Income 2019-2024 | RPRX

Royalty Pharma net income for the twelve months ending September 30, 2024 was $1.145B, a 520.96% increase year-over-year.

  • Royalty Pharma annual net income for 2023 was $1.135B, a 2549.5% increase from 2022.
  • Royalty Pharma annual net income for 2022 was $0.043B, a 93.09% decline from 2021.
  • Royalty Pharma annual net income for 2021 was $0.62B, a 36.44% decline from 2020.

Royalty Pharma Net Income 2019-2024 | RPRX

  • Royalty Pharma annual net income for 2023 was $1.135B, a 2549.5% increase from 2022.
  • Royalty Pharma annual net income for 2022 was $0.043B, a 93.09% decline from 2021.
  • Royalty Pharma annual net income for 2021 was $0.62B, a 36.44% decline from 2020.